Treatment of systemic lupus erythematosis

A method of treating swollen lymph node symptoms in an SLE patient comprising orally administering a dose of vitamin D compound effective to reduce or eliminate swollen lymph nodes to an individual susceptible to SLE patient with a calcium intake level of at least 800 mg/day/160 patient wherein the vitamin D compound is selected from the group of 1,25-dihydroxyvitamin D3, 19-nor-1,25-dihydroxyvitamin D2, 19-nor-21-epi-1,25-dihydroxyvitamin D3, 1,25-dihydroxy-24-homo-22-dehydro-22E vitamin D3, and 19-nor-1,25-dihydroxy-24-homo-22-dehydro-22E-vitamin D3.

A method of treating SLE symptoms in individuals susceptible to SLE, comprising orally administering an amount of vitamin D compound effective to prevent symptoms in the individual to an individual susceptible to SLE with a calcium intake level of at least 800 mg/day/160 patient wherein the vitamin D compound is selected from the group of 1,25-dihydroxyvitamin D3, 19-nor-1,25-dihydroxyvitamin D2, 19-nor-21-epi-1,25-dihydroxyvitamin D3, 1,25-dihydroxy-24-homo-22-dehydro-22E vitamin D3, and 19-nor-1,25-dihydroxy-24-homo-22-dehydro-22E-vitamin D3.